World Federation of Hemophilia/LinkedIn
Mar 2, 2026, 11:06
Advancing Visibility, Research, and Equitable Care on Rare Disease Day – WFH
World Federation of Hemophilia shared a post on LinkedIn:
“Rare Disease Day
For the World Federation of Hemophilia, this is a reminder that rare bleeding disorders deserve visibility, research, and equitable access to care.
At the WFH Congress 2026 in Kuala Lumpur, dedicated sessions will spotlight rare Bleeding Disorders, from complex clinical cases and emerging therapies to lived experiences and advocacy.
Let’s advance knowledge, strengthen community, and ensure no one is overlooked.
Explore the sessions and plan your experience.”
Other posts about World Federation of Hemophilia on Hemostasis Today.
-
Jun 4, 2026, 05:42Subramamyam Penubaku: Early Recognition and Risk-Based Management of Acute Pulmonary Embolism
-
Jun 4, 2026, 05:30Raghavendra Rao: Early Endothermal Ablation and Contemporary Management of Superficial Venous Thrombosis
-
Jun 4, 2026, 05:18Fouad Mikhail: Mechanical Thrombectomy and Anticoagulation in Intermediate-Risk Pulmonary Embolism
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity